$3.640
-0.050 (-1.36%)Zum Schluss
Profitabilität und Margen von IXHL
Evaluating the bottom line, Incannex Healthcare Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -117.17%, provide a clear picture of how effectively IXHL converts its operational activities into shareholder value.
IXHL im Vergleich zur Peergroup
In the context of the broader market, IXHL competes directly with industry leaders such as TVGN and FLNA. With a market capitalization of $43.55M, it holds a significant position in the sector. When comparing efficiency, IXHL's gross margin of N/A stands against TVGN's N/A and FLNA's N/A. Such benchmarking helps identify whether Incannex Healthcare Inc is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Incannex Healthcare Inc
The company has shown significant revenue fluctuations, with total revenue dropping to 0 in the last three quarters. Despite this, it has a current ratio of 47.51, suggesting strong liquidity to cover short-term obligations.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.